Keywords: اسید فنوفیبریک; Fenofibric acid; HPLC-UV; Pharmacokinetic; Mouse; Fenofibrate; Poorly water soluble drugs;
مقالات ISI اسید فنوفیبریک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اسید فنوفیبریک; AUC; area under the plasma concentration-time curve; BCS; biopharmaceutics classification system; FFA; fenofibric acid; FFB; fenofibrate; HCO40; NIKKOL HCO-40; HCO60; NIKKOL HCO-60; HPLC; high performance liquid chromatography; M1944; Labrafil® M 1944CS;
Keywords: اسید فنوفیبریک; CV; coefficients of variation; eROS; enzymatic reactive oxygen species; FA; fenofibric acid; FF; fenofibrate; HLMs; human liver microsomes; mROS; micellar reactive oxygen species; NaPB; sodium phosphate buffer; NBT; nitroblue tetrazolium; ROS; reactive ox
Keywords: اسید فنوفیبریک; Fenofibric acid; Controlled release pellet; Dissolution; Bioavailability; Bioequivalence
Keywords: اسید فنوفیبریک; AKR; Carbonyl reducing enzymes; Carbonyl reductase; Fenofibric acid; Reductive drug metabolism; Short-chain dehydrogenase/reductaseAKR, aldo-keto reductase; CLint, internal clearance; CREs, carbonyl reducing enzymes; SDR, short-chain dehydrogenase/reducta
Development and validation of bioanalytical UHPLC-UV method for simultaneous analysis of unchanged fenofibrate and its metabolite fenofibric acid in rat plasma: Application to pharmacokinetics
Keywords: اسید فنوفیبریک; Fenofibrate; Fenofibric acid; Method validation; RP-UHPLC; Pharmacokinetics;
Beneficial effects of fenofibric acid on overexpression of extracellular matrix components, COX-2, and impairment of endothelial permeability associated with diabetic retinopathy
Keywords: اسید فنوفیبریک; Fenofibric acid; Fibronectin; Collagen type IV; Retinal endothelial cells;
Rare LPL gene variants attenuate triglyceride reduction and HDL cholesterol increase in response to fenofibric acid therapy in individuals with mixed dyslipidemia
Keywords: اسید فنوفیبریک; Fenofibric acid; LPL gene variants; High-density lipoprotein cholesterol; Dyslipidemia;
Effect of ABT-335 (fenofibric acid) on meal-induced oxidative stress in patients with metabolic syndrome
Keywords: اسید فنوفیبریک; ABT-335; Fenofibric acid; Metabolic syndrome; Postprandial lipemia; Oxidative susceptibility;
A Randomized, Double-Blind Study of Fenofibric Acid Plus Rosuvastatin Compared With Rosuvastatin Alone in Stage 3 Chronic Kidney Disease
Keywords: اسید فنوفیبریک; chronic kidney disease; clinical trial; dyslipidemia; fenofibric acid; randomized
Attainment of goal/desirable lipid levels in patients with mixed dyslipidemia after 12 weeks of treatment with fenofibric acid and rosuvastatin combination therapy: A pooled analysis of controlled studies
Keywords: اسید فنوفیبریک; Fenofibric acid; Rosuvastatin; Combination therapy; Mixed dyslipidemia; Lipoproteins;
Effects of combination therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein (≥2 mg/L)
Keywords: اسید فنوفیبریک; Cardiovascular risk; C-reactive protein; Dyslipidemia; Fenofibric acid; Rosuvastatin
Single-Dose Bioequivalence of 105-mg Fenofibric Acid Tablets Versus 145-mg Fenofibrate Tablets Under Fasting and Fed Conditions: A Report of Two Phase I, Open-Label, Single-Dose, Randomized, Crossover Clinical Trials
Keywords: اسید فنوفیبریک; administration; bioequivalence; clinical trials as topic; fenofibric acid; hyperlipidemias/blood/drug therapy; oral
Oxidation by-products and ecotoxicity assessment during the photodegradation of fenofibric acid in aqueous solution with UV and UV/H2O2
Keywords: اسید فنوفیبریک; Fenofibric acid; UV photolysis; UV/H2O2; Toxic by-products; Liquid chromatography; Mass spectrometry;
Catalytic ozonation of fenofibric acid over alumina-supported manganese oxide
Keywords: اسید فنوفیبریک; Heterogeneous catalytic ozonation; Manganese oxide; Fenofibric acid; Adsorption; Hydroxyl radicals;
Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: A phase 3 study
Keywords: اسید فنوفیبریک; Dyslipidemia; Cholesterol; Fibrates; Hydroxymethylglutaryl-CoA reductase inhibitors; Rosuvastatin; Fenofibric acid
Efficacy and safety of fenofibric acid in combination with a statin in patients with mixed dyslipidemia: Pooled analysis of three phase 3, 12-week randomized, controlled studies
Keywords: اسید فنوفیبریک; Data pooling; Dyslipidemia; Fenofibric acid; Fibrates; HDL cholesterol; Hydroxymethylglutaryl-CoA reductase inhibitors; LDL cholesterol; Triglycerides
Long-term safety and efficacy of fenofibric acid in combination with statin therapy for the treatment of patients with mixed dyslipidemia
Keywords: اسید فنوفیبریک; Cholesterol; Dyslipidemias; Fenofibric acid; Hydroxymethylglutaryl-CoA reductase inhibitors; Lipoproteins
An automated method for the simultaneous determination of pravastatin, 3-hydroxy isomeric metabolite, pravalactone and fenofibric acid in human plasma by sensitive liquid chromatography combined with diode array and tandem mass spectrometry detection
Keywords: اسید فنوفیبریک; Pravastatin; 3-Hydroxy isomeric metabolite; Pravalactone; Fenofibric acid; LC–DAD–MS/MS; Pharmacokinetics; Solid-phase extraction; Validation
Aldehyde oxidase 1 is highly abundant in hepatic steatosis and is downregulated by adiponectin and fenofibric acid in hepatocytes in vitro
Keywords: اسید فنوفیبریک; Adiponectin; Peroxisome proliferator-activated receptor-α; Hepatocyte; Aldehyde oxidase 1; Fenofibric acid; Fatty liver disease
Simultaneous determination of rosuvastatin and fenofibric acid in human plasma by LC-MS/MS with electrospray ionization: Assay development, validation and application to a clinical study
Keywords: اسید فنوفیبریک; Rosuvastatin; Fenofibric acid; Method validation; LC-MS/MS; Human plasma; Pharmacokinetics;